RESEARCH LIBRARY / 2026Nasal spray or vial? Start with the formulation, exposure, and study method. This guide makes delivery-route research easier to compare.
With optional research emails. Eligibility and checkout terms apply.
Look past the format. Read the method.
A worked comparison and a worksheet for evaluating route claims. Route is part of a study design. This guide compares the questions researchers ask about nasal and parenteral delivery, using oxytocin research as a worked example. It also explains why a liquid spray, vial, or capsule should be evaluated as a specific formulation.
A route comparison should ask where the material is expected to go, how exposure is measured, and what endpoint is being evaluated. Convenience is not evidence of equivalent exposure. Dose labels alone cannot demonstrate equivalence.
A 2020 human study compared standard nasal spray, a nasal nebulizer, and intravenous oxytocin using regional cerebral blood-flow measurements. Some findings related to systemic exposure, while others supported route-specific brain effects. It illustrates why route claims need direct testing. [1]
The Real Peptides catalog includes prepared Semax and Selank liquid sprays and separate peptide variants. Match the exact identity and format to your research method. An amidated analog should not be treated as interchangeable with the parent peptide without supporting evidence.
Your research map, checklists, and source links—in one free PDF.